Atorvastatin-Induced Absorption of Chronic Subdural Hematoma Is Partially Attributed to the Polarization of Macrophages
- 26 September 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Molecular Neuroscience
- Vol. 72 (3), 565-573
- https://doi.org/10.1007/s12031-021-01910-x
Abstract
As one of the main types of secondary craniocerebral injury, the onset, progression, and prognosis of chronic subdural hematoma (CSDH) are closely related to the local inflammation of intracranial hematoma. Atorvastatin is reported to be effective in the conservative treatment of CSDH. This study aimed to clarify whether atorvastatin regulated the inflammatory responses in CSDH by interfering with the function of macrophages. The rat CSDH model was prepared by repeated intracranial blood injection with velocity gradient, and MRI was applied to calculate the intracranial hematoma volume. Changes in rat nerve functions were evaluated by foot-fault and Morris water maze tests. Flow cytometry was applied to detect the number of total macrophages and the percentage of M1 or M2 macrophages. The expression of inflammatory factors was examined by ELISA and western blot. Western bolt was applied to detect the expression of proteins involved in the colony-stimulating factor 1 receptor (CSF-1R) signaling pathway. Our results showed that atorvastatin significantly accelerated the absorption of hematoma and improved the nerve functions of CSDH rats. In addition, atorvastatin treatment effectively suppressed the expression of TNF-α, IL-6, and IL-8 and promoted the expression of IL-10. The total number of macrophages was decreased, and the percentage of M2 macrophages was increased in the intracranial hematoma following atorvastatin treatment. Furthermore, atorvastatin increased the levels of M2-related genes and surface markers in BMDMs stimulated by lipopolysaccharides and IFNγ, and activated the CSF-1R signaling pathway. In conclusion, our study shows that atorvastatin could alleviate the symptoms of CSDH and promote hematoma ablation by polarizing macrophages to M2 type and regulating the inflammatory responses.Keywords
Funding Information
- the Beijing Tianjin Hebei Basic Research Cooperation Project (19JCZDJC64600(Z))
- National Key Research and Development Program of China (2017YFE0110400)
This publication has 29 references indexed in Scilit:
- Chronic subdural hematomaAsian Journal of Neurosurgery, 2016
- Mechanism of subdural effusion evolves into chronic subdural hematoma: IL-8 inducing neutrophil oxidative burstMedical Hypotheses, 2016
- Effect of ATorvastatin On Chronic subdural Hematoma (ATOCH): a study protocol for a randomized controlled trialTrials, 2015
- A rat model of chronic subdural hematoma: Insight into mechanisms of revascularization and inflammationBrain Research, 2015
- Anatomy of a Discovery: M1 and M2 MacrophagesFrontiers in Immunology, 2015
- Effects of atorvastatin on the inflammation regulation and elimination of subdural hematoma in ratsJournal of the Neurological Sciences, 2014
- Effects of atorvastatin on chronic subdural hematoma: A preliminary report from three medical centersJournal of the Neurological Sciences, 2013
- CHRONIC SUBDURAL HEMATOMAS TREATED BY BURR HOLE TREPANATION AND A SUBPERIOSTAL DRAINAGE SYSTEMNeurosurgery, 2009
- Role of angiogenic growth factors and inflammatory cytokine on recurrence of chronic subdural hematomaSurgical Neurology, 2009
- Chronic subdural haematoma: time to rationalize treatment?British Journal of Neurosurgery, 2004